These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16943898)

  • 1. Pacemaker prevention therapy in drug-refractory paroxysmal atrial fibrillation: reliability of diagnostics and effectiveness of prevention pacing therapy in Vitatron selection device.
    Terranova P; Valli P; Terranova P; Dell'Orto S; Greco EM
    Indian Pacing Electrophysiol J; 2006 Apr; 6(2):63-74. PubMed ID: 16943898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias.
    Lee MA; Weachter R; Pollak S; Kremers MS; Naik AM; Silverman R; Tuzi J; Wang W; Johnson LJ; Euler DE;
    J Am Coll Cardiol; 2003 Jun; 41(11):1926-32. PubMed ID: 12798559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy.
    Israel CW; Hügl B; Unterberg C; Lawo T; Kennis I; Hettrick D; Hohnloser SH;
    J Cardiovasc Electrophysiol; 2001 Oct; 12(10):1121-8. PubMed ID: 11699520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualized selection of pacing algorithms for the prevention of recurrent atrial fibrillation: Results from the VIP registry.
    Lewalter T; Yang A; Pfeiffer D; Ruiter J; Schnitzler G; Markert T; Asklund M; Przibille O; Welz A; Esmailzadeh B; Linhart M; Lüderitz B
    Pacing Clin Electrophysiol; 2006 Feb; 29(2):124-34. PubMed ID: 16492296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of atrial tachyarrhythmia episodes during the overdrive pacing period using the post-mode switch overdrive pacing (PMOP) algorithm.
    Pürerfellner H; Ruiter JH; Widdershoven JW; Van Gelder IC; Urban L; Kirchhof CJ; Havlicek A; Kornet L;
    Heart Rhythm; 2006 Oct; 3(10):1164-71. PubMed ID: 17018345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial.
    Padeletti L; Pürerfellner H; Mont L; Tukkie R; Manolis AS; Ricci R; Inama G; Serra P; Scheffer MG; Martins V; Warman EN; Vimercati M; Grammatico A; Boriani G;
    Heart Rhythm; 2015 Aug; 12(8):1717-25. PubMed ID: 25869753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AFTherapy study.
    Camm AJ; Sulke N; Edvardsson N; Ritter P; Albers BA; Ruiter JH; Lewalter T; Capucci PA; Hoffmann E;
    Europace; 2007 Dec; 9(12):1110-8. PubMed ID: 18042619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial.
    Boriani G; Manolis AS; Tukkie R; Mont L; Pürerfellner H; Santini M; Inama G; Serra P; Gulizia M; Samoilenko IV; Wolff C; Holbrook R; Gavazza F; Padeletti L;
    Heart Rhythm; 2015 Jun; 12(6):1192-200. PubMed ID: 25701774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of atrial preference pacing on atrial fibrillation electrophysiological substrate in Myotonic Dystrophy type 1 population.
    Russo V; Nigro G; DI Meo F; Papa AA; Cioppa ND; Proietti R; Russo MG; Calabrò R; Politano L
    Acta Myol; 2014 Dec; 33(3):127-35. PubMed ID: 25873781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
    J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia.
    Padeletti L; Pürerfellner H; Adler SW; Waller TJ; Harvey M; Horvitz L; Holbrook R; Kempen K; Mugglin A; Hettrick DA;
    J Cardiovasc Electrophysiol; 2003 Nov; 14(11):1189-95. PubMed ID: 14678133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial.
    Boriani G; Tukkie R; Manolis AS; Mont L; Pürerfellner H; Santini M; Inama G; Serra P; de Sousa J; Botto GL; Mangoni L; Grammatico A; Padeletti L;
    Eur Heart J; 2014 Sep; 35(35):2352-62. PubMed ID: 24771721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of "substrate fibrillators" and "trigger fibrillators" by pacemaker diagnostics.
    Yang A; Ruiter J; Pfeiffer D; Esmailzadeh B; Welz A; Hochhäusler M; Nickenig G; Lüderitz B; Lewalter T
    Heart Rhythm; 2006 Jun; 3(6):682-8. PubMed ID: 16731470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study.
    Sulke N; Silberbauer J; Boodhoo L; Freemantle N; Kamalvand K; O'Nunain S; Hildick-Smith D; Lloyd GW; Patel NR; Paul V
    Europace; 2007 Sep; 9(9):790-7. PubMed ID: 17562750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced pacemaker diagnostic features in the characterization of atrial fibrillation: impact on preventive pacing algorithms.
    Yang A; Hochhäusler M; Schrickel J; Bielik H; Shlevkov N; Schimpf R; Schwab JO; Esmailzadeh B; Schneider C; Mellert F; Welz A; Saborowski F; Lüderitz B; Lewalter T;
    Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):310-3. PubMed ID: 12687835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of rapid atrial pacing for termination of drug refractory atrial fibrillation: results of a dual chamber implantable cardioverter defibrillator trial.
    Gold MR; Leman RB; Euler DE
    Card Electrophysiol Rev; 2003 Dec; 7(4):341-4. PubMed ID: 15071249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac pacing device therapy for atrial dysrhythmias: how does it work?
    Irwin ME
    AACN Clin Issues; 2004; 15(3):377-90. PubMed ID: 15475812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.
    Kantharia BK; Freedman RA; Hoekenga D; Tomassoni G; Worley S; Sorrentino R; Steinhaus D; Wolkowicz JM; Syed ZA;
    Europace; 2007 Nov; 9(11):1024-30. PubMed ID: 17913697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of pacemaker therapy in the prevention of atrial fibrillation.
    Delfaut P; Prakash A; Giorgberidze I; Munsif AN; Mathew PP; Krol RB; Saksena S
    Semin Interv Cardiol; 1997 Dec; 2(4):219-25. PubMed ID: 9704356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.